ELMIRON® LAWSUITS FOR VISION PROBLEMS

What You Should Know:

  • Elmiron®, a prescription drug used to treat bladder pain or discomfort from interstitial cystitis, has been linked to a serious vision disorder called pigmentary maculopathy.
  • This condition resulting from Elmiron® use can be confused with or initially diagnosed as age-related macular degeneration, macular or pattern dystrophy, diabetic retinopathy, or certain other genetic retinal diseases.
  • Lawsuits have been filed by individuals who have developed vision problems after taking Elmiron®.
  • The lawsuits accuse the prescription drug manufacturers of manufacturing, marketing, and selling a pharmaceutical which they knew or should have known could cause eye issues, yet did not properly warn consumers, physicians, or the public.
  • Contact Borgess Law, LLC at (567) 455-5955 or toll-free at (844) LAW-9144 for a free, confidential and no-obligation consultation for additional information or if you believe you or a loved one could have a potential claim.

Elmiron®

Elmiron® is an FDA approved oral medication prescribed for interstitial cystitis. Interstitial cystitis is a chronic regional pain syndrome of the bladder and pelvis that predominately affects females, manifesting with urinary urgency and pain or discomfort. More than 1 million people in the United States are estimated to be affected by this condition, which can also disrupt sleep and lead to emotional stress. Elmiron® is thought to act by binding to the bladder’s epithelial lining, regulating irritation and cellular permeability.

Link to Eye Damage

Multiple scientific studies have linked Elmiron® to a specific type of progressive and permanent eye disease called pigmentary maculopathy.  Sometimes this condition resulting from Elmiron® use can be confused with or initially diagnosed as age-related macular degeneration, macular or pattern dystrophy, diabetic retinopathy, or certain other genetic retinal diseases.

What Are the Symptoms of Pigmentary Maculopathy?

Reported symptoms for patients experiencing potential Elmiron®-associated eye damage include:

  • Prolonged light to dark adaptation
  • Blurry vision
  • Difficulty reading
  • Metamorphopsia (lines look curvy)
  • Central vision loss
  • Loss of vision detail
  • Dimming of vision
  • Blind splits
  • Floaters
  • Blindness
  • Spots
  • Impaired color vision
  • Difficulty with near vision

Lawsuits

Lawsuits have been filed against various pharmaceutical manufactures by individuals who have suffered vision loss or other eye problems from taking Elmiron®. The lawsuits allege that the drugmakers failed to properly warn consumers, physicians, and the public that Elmiron® could cause vision significant visual damage, including pigmentary maculopathy.

How We Can Help:

Borgess Law, LLC is currently reviewing potential legal claims for individuals who have experienced eye or vision problems after taking Elmiron®. There is no charge for this review. Further, if the claim is one we are willing to pursue, there is no fee or expense owed unless a recovery is obtained.

Attorney Pamela Borgess, the founder of Borgess Law, LLC, has decades of experience with numerous national high-profile defective medical drug/device cases and can discuss your legal options. For more information about the Elmiron® litigation or to discuss a potential claim, contact Borgess Law at (567) 455-5955 or toll-free at (844) LAW-9144. You can also contact Borgess Law by submitting an online inquiry. Again, this consultation is free and confidential. We welcome any questions you may have.

*This blog does not contain medical advice and is not intended to substitute for professional medical advice, diagnosis, or treatment.  Please consult with your physician for personalized medical advice.